- Report
- October 2024
- 192 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- October 2023
- 150 Pages
Global
From €4352EUR$4,850USD£3,746GBP
- Report
- July 2023
- 108 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- March 2024
- 132 Pages
Global
From €852EUR$950USD£734GBP
Within the domain of E-Healthcare, Narrowband IoT (NB-IoT) chipsets play a crucial role in enabling a new generation of medical devices that can consistently and securely transmit data over long distances. These chipsets are especially beneficial for remote patient monitoring systems, which require efficient power consumption and reliable connectivity even in suboptimal conditions. By utilizing NB-IoT chipsets, E-Healthcare devices can achieve extended battery life and improved indoor coverage, allowing healthcare providers to monitor patients with chronic conditions or those undergoing post-operative recovery from a distance. This technology supports the transmission of data such as vital signs and medication adherence, facilitating timely interventions and personalized care plans. NB-IoT's integration into E-Healthcare is part of a larger trend towards the Internet of Medical Things (IoMT), where a network of connected devices serves to enhance diagnostic processes, treatment protocol development, and patient care management.
In the market of NB-IoT chipsets for E-Healthcare, several companies are recognized for their development and manufacturing efforts. Key players include Qualcomm Incorporated, a leader in wireless technology that develops chipsets catering to a wide range of IoT applications, including healthcare. Huawei Technologies Co., Ltd. is also prominent, providing its own suite of NB-IoT solutions designed to facilitate various E-Healthcare scenarios. Other notable companies include Intel Corporation, with its contributions to IoT and E-Healthcare through advanced chipsets, and MediaTek Inc., which continues to innovate in the Show Less Read more